NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular inspection and coating services, instrumentation, downhole tools, and drill bits. It also offers equipment and technologies for hydraulic fracture stimulation, including downhole multistage fracturing tools, pressure pumping trucks, blenders, sanders, hydration and injection units, flowline, and manifolds; coiled tubing units, and wireline units and tools; connections and liner hangers; onshore production consists of composite pipe, surface transfer and progressive cavity pumps, and artificial lift systems; and offshore production, such as floating production systems and subsea production technologies, as well as manufactures industrial pumps and mixers. In addition, the company provides substructures, derricks, and masts; cranes; jacking systems; pipe lifting, racking, rotating, and assembly systems; mud pumps; pressure control equipment; drives and generators; rig instrumentation and control systems; mooring, anchor, and deck handling machinery; equipment components for offshore wind construction vessels; and pipelay and construction systems. Further, the company offers spare parts, repair, and rentals as well as comprehensive remote equipment monitoring, technical support, field service, and customer training. The company was formerly known as National Oilwell Varco, Inc. and changed its name to NOV Inc. in January 2021. NOV Inc. was founded in 1862 and is based in Houston, Texas.

NOV Inc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bristol-Myers Squibb (BMY), Enovis (ENOV) and Lant...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), Enovis (ENOV) and Lantheus (LNTH)

Novatti Group ( ($AU:NOV) ) has issued an announcement. Novatti Group Limited has applied for quotation of 225,734 new ordinary fully paid shares o...

Novatti Seeks ASX Quotation for Additional Ordinary Shares

Novo Nordisk ( ($NVO) ) just unveiled an announcement. Novo Nordisk reported on August 10, 2026 the latest progress in its ongoing share repurchase...

Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion

An announcement from Novo Nordisk ( ($NVO) ) is now available. On 6 August 2026, Novo Nordisk disclosed a series of insider transactions involving ...

Novo Nordisk reports vesting of 100th Anniversary restricted shares to board and EVP

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mesoblast Limited (MEOBF), Cullinan Management (CGEM...

Analysts Are Bullish on These Healthcare Stocks: Mesoblast Limited (MEOBF), Cullinan Management (CGEM)

In a report released today, Sachin Jain from Bank of America Securities maintained a Hold rating on Novo Nordisk, with a price target of DKK350.00....

Bank of America Securities Sticks to Its Hold Rating for Novo Nordisk (0QIU)

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Novo Nordisk today and set a price target of DKK290.00. According to TipRanks,...

Deutsche Bank  Remains a Hold on Novo Nordisk (0QIU)

Barclays analyst James Gordon CFA maintained a Hold rating on Novo Nordisk today and set a price target of DKK310.00. According to TipRanks, Gordon...

Barclays Keeps Their Hold Rating on Novo Nordisk (0QIU)

Novanta ( ($NOVT) ) has issued an announcement. Novanta reported a strong second quarter of 2026, with GAAP revenue rising 10% year over year to ab...

Novanta Delivers Double‑Digit Growth and Margin Expansion in Second Quarter 2026

UBS analyst Matthew Weston maintained a Hold rating on Novo Nordisk today and set a price target of DKK332.00. According to TipRanks, Weston is ran...

UBS Keeps Their Hold Rating on Novo Nordisk (0QIU)

Novo Nordisk ( ($NVO) ) has issued an update. Novo Nordisk reported its adjusted financial performance for the second quarter of 2026 on 4 August 2...

Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results

An announcement from Novo Nordisk ( ($NVO) ) is now available. Novo Nordisk A/S reported progress on its previously announced share repurchase prog...

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Novo Nordisk today and set a price target of DKK250.00. According to TipRanks, Vosse...

J.P. Morgan Remains a Hold on Novo Nordisk (0QIU)

RBC Capital analyst Keith Mackey maintained a Hold rating on NOV today and set a price target of $22.00. According to TipRanks, Mackey is a 5-star ...

RBC Capital Sticks to Its Hold Rating for NOV (NOV)

TD Cowen analyst Marc Bianchi maintained a Buy rating on NOV today and set a price target of $26.00. According to TipRanks, Bianchi is a 4-star ana...

TD Cowen Reaffirms Their Buy Rating on NOV (NOV)

In a report released today, Stephen Gengaro from Stifel Nicolaus maintained a Buy rating on NOV, with a price target of $24.00. Gengaro covers the ...

Stifel Nicolaus Sticks to Its Buy Rating for NOV (NOV)

In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Hold rating on Novartis, with a price target of $147.00. The company...

Berenberg Bank Remains a Hold on Novartis (NVS)

Novanta ( ($NOVT) ) has issued an announcement. On July 23, 2026, Novanta completed its previously announced acquisition of Riverpoint Medical from...

Novanta Completes Riverpoint Medical Acquisition to Boost Growth

Novamarine S.P.A. ( ($IT:NOVA) ) has shared an update. Novamarine S.p.A., the Italian boatmaker listed on Euronext Growth Milan, has called an extr...

Novamarine Calls Extraordinary Meeting to Update Statutes and Authorize Capital Increase

WSW, NY, July 23rd, 2026, FinanceWire Nuvectis Pharma (NASDAQ:NVCT) announced this morning that ciprocopan (NXP100) has been approved by China’s Na...

Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor

DZ BANK AG analyst Elmar Kraus maintained a Hold rating on Novartis AG yesterday. The company’s shares closed yesterday at CHF125.34. Kraus covers ...

Novartis AG (NOVN) Gets a Hold from DZ BANK AG

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novartis AG, with a price target of CHF135.00. According to ...

Novartis AG (NOVN) Gets a Buy from J.P. Morgan

Novo Nordisk ( ($NVO) ) has shared an announcement. On 6 May 2026, Novo Nordisk A/S launched a share repurchase programme under EU Safe Harbour rul...

Novo Nordisk Ramps Up DKK 15 Billion Share Buyback Programme

Bernstein analyst Justin Smith maintained a Hold rating on Novartis AG today and set a price target of CHF125.00. According to TipRanks, Smith is a...

Novartis AG (NOVN) Receives a Hold from Bernstein

Jefferies analyst Michael Leuchten maintained a Hold rating on Novartis AG today and set a price target of CHF110.00. According to TipRanks, Leucht...

Jefferies Keeps Their Hold Rating on Novartis AG (NOVN)

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Novo Nordisk, with a price target of DKK290.00. Accor...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NOV	$21.14	0.00%	2.62M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NOV	$21.14	0%	2.62M
3
4
5
6

NOV

Get NOV Inc. Data in Excel

Get NOV Inc. Data in Excel